• PPM-18: From NF-κB Biology to Translational Insight

  2026-09-11

  PPM-18, also known as N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide, offers a pathway-focused approach to studying NF-κB-driven iNOS expression. This thought-leadership analysis connects its macrophage and endotoxemia evidence with bone-remodeling research, while defining practical validation steps and translational limits.

• Captopril: ACE Inhibitor Workflows

  2026-09-10

  Captopril enables mechanism-focused ACE inhibition studies, with practical controls that distinguish angiotensin I pathway effects from nonspecific activity. This guide also shows how to translate its use into oncology and gastrointestinal assays without overstating what the supporting reference directly demonstrated.

• CHIR 99021 Trihydrochloride in Organoid Workflows

  2026-09-10

  CHIR 99021 trihydrochloride provides selective GSK-3α/β inhibition for tuning stem-cell state, organoid growth, and metabolic assays. This practical guide connects concentration-ranging, reversible differentiation workflows, and troubleshooting to the tunable intestinal organoid strategy reported in recent research.

• Senescent Beta Cells and Type 1 Diabetes Prevention

  2026-09-09

  Thompson et al. identify senescent pancreatic beta cells as active contributors to type 1 diabetes pathogenesis rather than passive targets of immune attack. Their work links beta-cell senescence, Bcl-2-dependent survival, and immune-mediated tissue destruction, showing in NOD mice that pharmacological clearance of senescent beta cells can preserve beta-cell mass and prevent diabetes.

• Carbenoxolone disodium: Practical Lab Guide

  2026-09-09

  Carbenoxolone disodium (SKU A8389) is a research reagent for probing 11β-hydroxysteroid dehydrogenase activity, glucocorticoid access, and gap junction communication in cell or tissue workflows. It is best used as an exploratory mechanistic perturbation with vehicle, viability, and pathway controls, not as a selective target-validation compound or an in vivo efficacy treatment.

• CSBTA Pharmacokinetics in MASH Mice

  2026-09-08

  The reference study integrates plasma pharmacokinetics, tissue distribution, transporter assays, and metabolic-enzyme analysis to explain how HFHCD-induced MASH changes the disposition of Corydalis saxicola Bunting total alkaloids. Its findings indicate that disease state and repeated dosing can increase systemic exposure, hepatic distribution, and hepatocyte accumulation, with CYP450 enzymes, Oatp1b2, P-gp, and PXR implicated in the variability.

• CX-5461: From Pol I Blockade to Assay Design

  2026-09-08

  CX-5461 is an RNA polymerase I inhibitor that connects ribosome biogenesis stress with DNA damage, mitotic catastrophe, autophagy, and senescence. This article presents a practical assay framework for interpreting its activity in cancer research beyond simple viability measurements.

• Bicinchoninic Acid Assay (BCA) Kit Guide

  2026-09-07

  The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit, SKU K4102, measures low-concentration total protein in biochemical samples and cell lysates, including many detergent-containing preparations. It is intended for scientific research and sample-normalization workflows, not diagnostic, clinical, or medical testing.

• CKI 7 Dihydrochloride: CK1 Inhibitor Guide

  2026-09-07

  CKI 7 dihydrochloride is an ATP-competitive Casein kinase 1 inhibitor for controlled studies of CK1-dependent phosphorylation. Its defined identity, solubility limits, and storage requirements support biochemical, Wnt, circadian, and cancer biology research, but the compound does not by itself establish pathway specificity or therapeutic activity.

• Glycogen Colorimetric Assay Kit II for Exercise Studies

  2026-09-05

  The Glycogen Colorimetric Assay Kit II provides a practical way to compare liver and muscle glycogen across training time points, circadian phases, and metabolic models. Its hydrolysis-based, 450 nm readout is especially useful when reducing substances make conventional oxidase-based measurements difficult.

• 2,2,2-Trichloroethanol for Orthogonal Protein Assays

  2026-09-04

  Discover how 2,2,2-Trichloroethanol can support protein-level quality control without being confused with a dopamine imaging tracer. This evidence-focused guide connects electrophoretic analysis with the longitudinal DAT imaging strategy reported in a preclinical Parkinson’s disease model.

• Trilaurin: Practical Lab Protocols

  2026-09-04

  Trilaurin, also called Glycerol Tridodecanoate, provides a defined C12 triacylglycerol for solvent-based formulation studies and enzymatic substrate screening. It should be treated as a research reagent rather than assumed to improve oral delivery, immune responses, or therapeutic outcomes without matched validation, particularly because it is water-insoluble and directly matched paper evidence is not available here.

• EZ Cap™ EPO mRNA: A Decision Framework

  2026-09-03

  EZ Cap™ EPO mRNA supports controlled human erythropoietin expression in erythropoiesis, neuroprotection, and protein expression studies. This article presents an assay-centered framework for selecting controls, delivery systems, readouts, and interpretation boundaries rather than treating mRNA design as a standalone variable.

• Decitabine Priming Expands Progenitor Tex in PD-1 Therapy

  2026-09-03

  Li et al. show that low-dose Decitabine, also known as 5-Aza-2'-deoxycytidine, improves anti–PD-1 activity by expanding and functionally maintaining CD8+ progenitor exhausted T cells rather than simply increasing short-term T-cell activation. The study connects epigenetic priming to sustained JunD and JNK/AP-1 activity, offering a mechanistic framework for combination immunotherapy research.

• MCC950 Sodium for NLRP3 Assay Workflows

  2026-09-02

  MCC950 sodium, also known as CRID3 sodium salt, enables selective NLRP3 inflammasome inhibition across macrophage, neuroinflammation, and autoimmune disease workflows. This guide connects robust cell-based assay design with the astrocyte-focused morphine-tolerance findings reported in a 2024 reference study.

8566 records 1/572 page Next 12345 下5页 Last page